Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease

This study has been completed.
Sponsor:
Collaborator:
Huntington Study Group
Information provided by:
Amarin Neuroscience Ltd
ClinicalTrials.gov Identifier:
NCT00146211
First received: September 2, 2005
Last updated: December 24, 2007
Last verified: December 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2007
  Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)
No publications provided by Amarin Neuroscience Ltd

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):